Last week we received significant funding from the Dutch Cancer Society (KWF) for our work on leukemia, lymphoma and neuroblastoma.


2 project grants:
- Jürgen Kuball, Zsolt Sebestyen and Dennis Beringer received 650 keuro for the use of gdTCR anti CD3 bispecific molecules (GABs) for AML

- Jeanette Leusen received 550 keuro for the use of IgA as new isotype for the treatment of lymphoma and neuroblastoma, in combination with innate checkpoint inhibition


2 high-risk from Alpe d'HuZes:
- Stefan Nierkens together with Femke van Wijk and Jaap Jan Boelens received 187 keuro for the development of a new method for T cell therapy of recidial, pediatric leukemia

- Niels Bovenschen together with Wim Hennink received 150 keuro for nano medication mimicking effector immune response.

Together this is over 1.5 million euro's funding to support our research against cancer.

Comment